Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 4 47-4, 2003, Pages

  Loureiro Silva, Mauricio R ^a   Cadelina, Gregory W ^b   Groszmann, Roberto J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Ascites; Liver microcirculation; Nitric oxide synthase; Rat liver perfusion; Wedged hepatic venous pressure

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; METHOXAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; BLOOD VESSEL TONE; CONTROLLED STUDY; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER PERFUSION; LIVER SINUSOID; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0345118191     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00452.2002     Document Type: Article

References (39)

1. Albillos A, Llebo JL, Banares R, Rossi I, Iborra J, Calleja J1 Garrido A, Escartin P, and Bosch J. Hemodynamic effects of α-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension. Hepatology 20: 611-617, 1994.
2. Alexander RS. Critical closure reexamined. Circ Res 40: 531-535, 1977.
3. Angelico M, Carli L, Piat C, Gentile S, and Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 113: 1632-1639, 1997.
4. Bhathal PS and Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1: 325-337, 1985.
5. Clemens MG and Zhang JX. Regulation of sinusoidal perfusion: in vivo methodology and control by endothelins. Semin Liver Dis 19: 383-396, 1999.
6. Conrad WA. Pressure-flow relationship in collapsible tubes. IEEE Trans Biomed Eng 16: 284-295, 1969.
7. Dudenhoefer AA, Loureiro-Silva MR, Cadelina GW, Gupta T, and Groszmann RJ. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic livers. Hepatology 36: 381-385, 2002.
8. Fiorucci S, Antonelli E, Morelli O, Mencarelli A, Casini A, Mello T, Palazzetti B, Tallet D, del Soldato P, and Morelli A. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci USA 15: 8897-8902, 2001.
9. Freeman J, Barton J, and Record C. Effect of isosorbide dinitrate, verapamil and labetalol on portal pressure in cirrhosis. Br Med J 291: 561-562, 1985.
10. Gandhi CR, Sproat LA, and Subbotin VM. Increased hepatic endothelin-1 levels and endothelin receptors density in cirrhotic rat livers. Life Sci 58: 55-62, 1996.
11. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 120: 726-748, 2001.
12. Godfrey K. Comparing the means of several groups. N Engl J Med 313: 1450-1456, 1985.
13. Gores GJ, Kost LJ, and LaRusso NF. The isolated perfused rat liver: conceptual and practical considerations. Hepatology 6: 511-517, 1986.
14. Grossman HJ and Bhathal PS. Application of isolated perfused rat liver preparation to pharmacological studies of the intrahepatic vascular bed. Methods Find Exp Clin Pharmacol 6: 33-40, 1984.
15. Groszmann RJ. The hepatic venous pressure gradient: has the time arrived for its application in clinical practice? Hepatology 24: 739-740, 1996.
16. Groszmann RJ and de Franchis R. Portal hypertension. In: Schiff's diseases of the liver (8th ed.), edited by Schiff ER, Sorrell MF, and Maddrey WC. Philadelphia, PA: Lippincott-Raven, 1999, p. 387-441.
17. Gupta TK, Toruner M, Chung MK, and Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28: 926-931, 1998.
18. Hallemans R, Naije R, Mols P, Mélot C, and Reding P. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin. Crit Care Med 11: 536-540, 1983.
19. Hamilton RL, Berry MN, Williams MC, and Severinghaus EM. A simple and inexpensive membrane lung for small organ perfusions. J Lipid Res 15: 182-186, 1974.
20. Heller J, Schepke M, Gehnen N, Molderings GJ, Muller A, Erhard J, Spengler U, and Sauerbruch T. Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. Gastroenterology 116: 387-393, 1999.
21. Jenkins SA, Baxter JN, Johnson JN, Devitt P, and Shields R. Effects of propranolol on hepatic hemodynamics in the cirrhotic and non-cirrhotic rat. Br J Surg 72: 354-358, 1985.
22. Kawada N, Tran-Thi TA, Klein H, and Decker K. The contraction of stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tone. Eur J Biochem 213: 815-823, 1993.
23. Laffi G, Foschi M, Masini E, Simoni A, Mugnai L, La Villa G, Barletta G, Mannaioni PF, and Gentilini P. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 22: 1666-1673, 1995.
24. Lebrec D, Lacroix S, and Benhamou JP. Hepatic vein catheterization in the rat. Pflügers Arch 387: 67-68, 1980.
25. Lopez-Novoa JM. Pathophysiological features of carbon tetrachloride/phenobarbital model of experimental liver cirrhosis in rats. In: The Kidney in Liver Disease (3rd ed.), edited by Epstein M. New York: Elsevier, 1988, p. 309-327.
26. 2-type receptor and modulated by nitric oxide. Int Hepatol Commun 4: 175-180, 1995.
27. Mittal MK, Gupta TK, Lee FY, Sieber CC, and Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol Gastrointest Liver Physiol 267: G416-G422, 1994.
28. Mitzner W. Hepatic outflow resistance, sinusoid pressure, and the vascular waterfall. Am J Physiol 227: 513-519, 1974.
29. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, and Bosh J. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117: 626-631, 1999.
30. Myers JD and Taylor WJ. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest 30: 662-663, 1951.
31. Navasa M, Chesta J, Bosch J, and Rodes J. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. Gastroenterology 96: 1110-1118, 1989.
32. Ossenberg FW, Denis P, and Benhamou JP. Hepatic blood flow in the rat: effect of portacaval shunt. J Appl Physiol 37: 806-808, 1974.
33. Pannen BHJ, Bauer M, Zhang JX, Robotham JL, and Clemens MG. A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin. Am J Physiol Heart Circ Physiol 271: H1953-H1961, 1996.
34. Pinzani M, Milani S, Franco R, Grappone C, Caligiuri A, Gantilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, and Gentilini P. Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110: 534-548, 1996.
35. Ring-Larsen H, Hesse B, Henriksen LH, and Christensen NJ. Sympathetic nervous activity and renal systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release. Hepatology 2: 304-310, 1982.
36. Rockey DC and Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat livers: endothelial dysfunction in portal hypertension. Gastroenterology 114: 344-351, 1998.
37. Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F, and Rodes J. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 21: 554-560, 1995.
38. Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, and Keefer LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J Med Chem 40: 1947-1954, 1997.
39. Shah V, Haddad FG, Garcia-Gardena G, Frangos JA, Mennone A, Groszmann RJ, and Sessa WC. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in hepatic sinusoids. J Clin Invest 100: 2923-2930, 1997.